[开放获取]    从心身医学视角认识玫瑰痤疮

doi:10.35541/cjd.20230451

中华皮肤科杂志 ›› 2024, Vol. 57 ›› Issue (2): 123-126.doi: 10.35541/cjd.20230451

[开放获取] 从心身医学视角认识玫瑰痤疮

蒋献,宋德宇

四川大学华西医院皮肤性病科四川大学疾病分子网络前沿科学中心免疫炎症研究院皮肤病学研究室，成都 610041

收稿日期:2023-08-07 修回日期:2023-08-17 发布日期:2024-02-01
通讯作者: 蒋献 E-mail:jiangxian@scu.edu.cn
基金资助:
国家自然科学基金（82273559、82073473）

Insights into rosacea from the perspective of psychosomatic medicine

Jiang Xian, Song Deyu

Department of Dermatology and Venereology, West China Hospital, Sichuan University; Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, China

Received:2023-08-07 Revised:2023-08-17 Published:2024-02-01
Contact: Jiang Xian E-mail:jiangxian@scu.edu.cn
Supported by:
National Natural Science Foundation of China（82273559、82073473）

摘要/Abstract

摘要： 【摘要】玫瑰痤疮是一种心身疾病，具有独特的神经生物学发病基础，存在较多神经精神疾病共病风险，且其社会心理负担突出。本文从神经、精神、社会、心理等角度探讨玫瑰痤疮的心身特点，以增进皮肤科医师对该病心身属性的认识。

关键词: 红斑痤疮, 心身医学, 神经精神疾病, 心理社会因素

Abstract: 【Abstract】 Rosacea is a psychosomatic disorder characterized by a distinct neurobiological etiology. It is prone to be comorbid with many neuropsychiatric conditions, and imposes a significant psychosocial burden. This article discusses the psychosomatic attributes of rosacea from neurological, psychiatric, social, and psychological perspectives, aiming to enhance dermatologists′ understanding of its psychosomatic nature.

Key words: Rosacea, Psychosomatic medicine, Neuropsychiatric diseases, Psychosocial factors

蒋献宋德宇. [开放获取] 从心身医学视角认识玫瑰痤疮[J]. 中华皮肤科杂志, 2024,57(2):123-126. doi:10.35541/cjd.20230451

Jiang Xian, Song Deyu. Insights into rosacea from the perspective of psychosomatic medicine[J]. Chinese Journal of Dermatology, 2024, 57(2): 123-126.doi:10.35541/cjd.20230451

参考文献 44

［1］	刘国艳, 高强, 张晓杰. 皮肤病患者心身现状与心理行为干预［J］. 国际皮肤性病学杂志, 2010,36（5）:279⁃281. doi: 10.3760/cma.j.issn.1673⁃4173.2010.05.013.
［2］	袁勇贵, 岳莹莹. 中国心身医学学科发展方向和机遇［J］. 东南大学学报（医学版）, 2020,39（5）:557⁃561. doi: 10.3969/j.issn.1671⁃6264.2020.05.001.
［3］	Whitlock FA. Psychosomatic aspects of rosacea［J］. Br J Dermatol, 1961,73:137⁃148. doi: 10.1111/j.1365⁃2133.1961.tb14422.x.
［4］	Jin R, Luo L, Zheng J. The trinity of skin: skin homeostasis as a neuro⁃endocrine⁃immune organ［J］. Life （Basel）, 2022,12（5）:725. doi: 10.3390/life12050725.
［5］	Schwab VD, Sulk M, Seeliger S, et al. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea［J］. J Investig Dermatol Symp Proc, 2011,15（1）:53⁃62. doi: 10.1038/jidsymp.2011.6.
［6］	Kim HB, Na EY, Yun SJ, et al. The effect of capsaicin on neuroinflammatory mediators of rosacea［J］. Ann Dermatol, 2022,34（4）:261⁃269. doi: 10.5021/ad.21.223.
［7］	Brinnel H, Friedel J, Caputa M, et al. Rosacea: disturbed defense against brain overheating［J］. Arch Dermatol Res, 1989,281（1）:66⁃72. doi: 10.1007/BF00424276.
［8］	Metzler⁃Wilson K, Toma K, Sammons DL, et al. Augmented supraorbital skin sympathetic nerve activity responses to symptom trigger events in rosacea patients［J］. J Neurophysiol, 2015,114（3）:1530⁃1537. doi: 10.1152/jn.00458.2015.
［9］	Wienholtz N, Christensen CE, Coskun H, et al. Infusion of pituitary adenylate cyclase⁃activating polypeptide⁃38 in patients with rosacea induces flushing and facial edema that can be attenuated by sumatriptan［J］. J Invest Dermatol, 2021,141（7）:1687⁃1698. doi: 10.1016/j.jid.2021.02.002.
［10］	Liu Y, Xu Y, Guo Z, et al. Identifying the neural basis for rosacea using positron emission tomography⁃computed tomography cerebral functional imaging analysis: a cross⁃sectional study［J］. Skin Res Technol, 2022,28（5）:708⁃713. doi: 10.1111/srt.13171.
［11］	Wienholtz N, Christensen CE, Zhang DG, et al. Clinical characteristics of combined rosacea and migraine［J］. Front Med （Lausanne）, 2022,9:1026447. doi: 10.3389/fmed.2022.1026447.
［12］	Sinikumpu SP, Vähänikkilä H, Jokelainen J, et al. Male patients with rosacea have increased risk for migraine: a population⁃based study［J］. Br J Dermatol, 2021,185（5）:1058⁃1061. doi: 10.1111/bjd.20578.
［13］	Egeberg A, Hansen PR, Gislason GH, et al. Exploring the association between rosacea and parkinson disease: a danish nationwide cohort study［J］. JAMA Neurol, 2016,73（5）:529⁃534. doi: 10.1001/jamaneurol.2016.0022.
［14］	Mathieu RJ, Guido N, Ibler E, et al. Rosacea and subsequent diagnosis for Parkinson′s disease: a large, urban, single center, US patient population retrospective study［J］. J Eur Acad Dermatol Venereol, 2018,32（4）:e141⁃e144. doi: 10.1111/jdv. 14638.
［15］	Egeberg A, Hansen PR, Gislason GH, et al. Patients with rosacea have increased risk of dementia［J］. Ann Neurol, 2016,79（6）:921⁃928. doi: 10.1002/ana.24645.
［16］	Long J, Li J, Yuan X, et al. Potential association between rosacea and cancer: a study in a medical center in southern China［J］. J Dermatol, 2019,46（7）:570⁃576. doi: 10.1111/1346⁃8138.14918.
［17］	Woo YR, Han YJ, Kim HS, et al. Updates on the risk of neuropsychiatric and gastrointestinal comorbidities in rosacea and its possible relationship with the Gut⁃Brain⁃Skin Axis［J］. Int J Mol Sci, 2020,21（22）:8427. doi: 10.3390/ijms21228427.
［18］	Lukaviciute L, Ganceviciene R, Navickas P, et al. Anxiety, depression, and suicidal ideation amongst patients with facial dermatoses （acne, rosacea, perioral dermatitis, and folliculitis） in Lithuania［J］. Dermatology, 2020,236（4）:314⁃322. doi: 10. 1159/000506627.
［19］	Chang HC, Huang YC, Lien YJ, et al. Association of rosacea with depression and anxiety: a systematic review and meta⁃analysis［J］. J Affect Disord, 2022,299:239⁃245. doi: 10.1016/j.jad.2021.12.008.
［20］	Wang Z, Xie H, Gong Y, et al. Relationship between rosacea and sleep［J］. J Dermatol, 2020,47（6）:592⁃600. doi: 10.1111/1346⁃8138.15339.
［21］	Aktaş Karabay E, Karşıyakalı N, Karabay E. Evaluation of sexual functions in female rosacea patients: a prospective, case⁃control study［J］. Int J Impot Res, 2020,32（6）:628⁃634. doi: 10.1038/s41443⁃020⁃0275⁃z.
［22］	Scharschmidt TC, Yost JM, Truong SV, et al. Neurogenic rosacea: a distinct clinical subtype requiring a modified approach to treatment［J］. Arch Dermatol, 2011,147（1）:123⁃126. doi: 10.1001/archdermatol.2010.413.
［23］	Li M, Tao M, Zhang Y, et al. Neurogenic rosacea could be a small fiber neuropathy［J］. Front Pain Res （Lausanne）, 2023,4:1122134. doi: 10.3389/fpain.2023.1122134.
［24］	Wu Y, Fu C, Zhang W, et al. The dermatology life quality index （DLQI） and the hospital anxiety and depression （HADS） in Chinese rosacea patients［J］. Psychol Health Med, 2018,23（4）:369⁃374. doi: 10.1080/13548506.2017.1361540.
［25］	Yang F, Wang L, Shucheng H, et al. Differences in clinical characteristics of rosacea across age groups: a retrospective study of 840 female patients［J］. J Cosmet Dermatol, 2023,22（3）:949⁃957. doi: 10.1111/jocd.15470.
［26］	Chen M, Deng Z, Huang Y, et al. Prevalence and risk factors of anxiety and depression in rosacea patients: a cross⁃sectional study in China［J］. Front Psychiatry, 2021,12:659171. doi: 10.3389/fpsyt.2021.659171.
［27］	李健, 宋志强. 玫瑰痤疮面部潮红与红斑新认识［J］. 中华皮肤科杂志, 2021,54（4）:360⁃363. doi: 10.35541/cjd.20190920.
［28］	Huynh TT. Burden of Disease: The psychosocial impact of rosacea on a patient′s quality of life［J］. Am Health Drug Benefits, 2013,6（6）:348⁃354.
［29］	Li J, Tang JY, Fu J, et al. Carvedilol ameliorates persistent erythema of erythematotelangiectatic rosacea by regulating the status of anxiety/depression［J］. J Dermatol, 2022,49（11）:1139⁃1147. doi: 10.1111/1346⁃8138.16525.
［30］	Drummond PD, Su D. Blushing in rosacea sufferers［J］. J Psychosom Res, 2012,72（2）:153⁃158. doi: 10.1016/j.jpsychores. 2011.09.002.
［31］	Halioua B, Cribier B, Frey M, et al. Feelings of stigmatization in patients with rosacea［J］. J Eur Acad Dermatol Venereol, 2017,31（1）:163⁃168. doi: 10.1111/jdv.13748.
［32］	Böhm D, Schwanitz P, Stock Gissendanner S, et al. Symptom severity and psychological sequelae in rosacea: results of a survey［J］. Psychol Health Med, 2014,19（5）:586⁃591. doi: 10. 1080/13548506.2013.841968.
［33］	Hassan S, Mohammed TO, Hoenig LJ. Bardolph′s rosacea: skin disorders that define personality in Shakespeare′s plays［J］. Clin Dermatol, 2019,37（5）:600⁃603. doi: 10.1016/j.clindermatol.2019. 07.021.
［34］	Dirschka T, Micali G, Papadopoulos L, et al. Perceptions on the psychological impact of facial erythema associated with rosacea: results of international survey［J］. Dermatol Ther （Heidelb）, 2015,5（2）:117⁃127. doi: 10.1007/s13555⁃015⁃0077⁃2.
［35］	Karlsson E, Berg M, Arnetz BB. Rosacea and personality［J］. Acta Derm Venereol, 2004,84（1）:76⁃77. doi: 10.1080/0001555 0310005799.
［36］	杨赛, 谢红付, 邓宇瑄, 等. A型性格与玫瑰痤疮的相关性研究［J］. 临床皮肤科杂志, 2014,43（12）:707⁃709.
［37］	Alinia H, Moradi Tuchayi S, Farhangian ME, et al. Rosacea patients seeking advice: qualitative analysis of patients′ posts on a rosacea support forum［J］. J Dermatolog Treat, 2016,27（2）:99⁃102. doi: 10.3109/09546634.2015.1133881.
［38］	Riddoch LH. It takes one to know one: exploring patient dialogue on rosacea web⁃based platforms and their potential for significant harm［J］. J Dermatolog Treat, 2019,30（1）:52⁃62. doi: 10.1080/09546634.2018.1468067.
［39］	Johnston SA, Krasuska M, Millings A, et al. Experiences of rosacea and its treatment: an interpretative phenomenological analysis［J］. Br J Dermatol, 2018,178（1）:154⁃160. doi: 10.1111/bjd.15780.
［40］	Carter C, Martin K, Gordon C, et al. Exploring the lived experience of women with rosacea: visible difference and psychological impact［J］. Br J Dermatol, 2022,186（2）:366⁃367. doi: 10.1111/bjd.20768.
［41］	Wang B, Huang Y, Tang Y, et al. Paroxetine is an effective treatment for refractory erythema of rosacea: primary results from the Prospective Rosacea Refractory Erythema Randomized Clinical Trial［J］. J Am Acad Dermatol, 2023,88（6）:1300⁃1307. doi: 10.1016/j.jaad.2023.01.044.
［42］	中华医学会皮肤性病学分会玫瑰痤疮研究中心, 中国医师协会皮肤科医师分会玫瑰痤疮专业组. A型肉毒毒素皮内注射治疗玫瑰痤疮持久性红斑及潮红专家共识［J］. 中华皮肤科杂志, 2023,56（1）:16⁃21. doi: 10.35541/cjd.20220390.
［43］	Drott C, Claes G, Olsson⁃Rex L, et al. Successful treatment of facial blushing by endoscopic transthoracic sympathicotomy［J］. Br J Dermatol, 1998,138（4）:639⁃643. doi: 10.1046/j.1365⁃2133. 1998.02176.x.
［44］	Magid M, Reichenberg JS. An evidence⁃based approach to starting a psychodermatology clinic［J］. JAMA Dermatol, 2020,156（6）:617⁃618. doi: 10.1001/jamadermatol.2020.0393.

[1]	张悦陶梦李敏姜沛彧刘韵祎刘乙萱潘婼芯许阳. 玫瑰痤疮病情评价标准研究进展[J]. 中华皮肤科杂志, 2024, 57(2): 182-185.
[2]	潘婼芯顾多多张悦李敏陶梦许阳. 代谢组学在玫瑰痤疮研究中的应用进展[J]. 中华皮肤科杂志, 2024, 57(2): 178-181.
[3]	魏子妤杨勇. 离子通道与玫瑰痤疮发病机制的研究进展[J]. 中华皮肤科杂志, 2024, 57(2): 174-177.
[4]	刘亭微孟潇琦顾多多潘婼芯张悦许阳. 玫瑰痤疮发病机制的研究进展[J]. 中华皮肤科杂志, 2024, 57(2): 186-190.
[5]	李吉谢红付. 如何避免玫瑰痤疮的误诊[J]. 中华皮肤科杂志, 2024, 57(2): 119-122.
[6]	那君李若瑜仲少敏杨莉吴艳. 玫瑰痤疮真实世界诊疗现状调查分析[J]. 中华皮肤科杂志, 2024, 57(2): 127-133.
[7]	马光荣谢红付刘家双周钟莲周淞麒黄莹雪李吉. 玫瑰痤疮患者小肠细菌过度生长情况调查及临床特征分析[J]. 中华皮肤科杂志, 2024, 57(2): 134-140.
[8]	张晓东汪蔓雅朱英杰骆天德刘小明. 荧光染色法在面部皮肤蠕形螨检查中的应用评估[J]. 中华皮肤科杂志, 2023, 56(8): 766-769.
[9]	陶梦李敏刘乙萱刘韵祎姜沛彧张嘉文南宇晴许阳. 玫瑰痤疮与精神神经性疾病相关性研究进展[J]. 中华皮肤科杂志, 2023, 56(7): 693-697.
[10]	米淑宏余艳琴郝金奇李薇张杨贾喜梅黄毓娴孙怀玉石继海. 丘疹脓疱型玫瑰痤疮患者皮肤高频超声联合彩色多普勒血流成像的特征[J]. 中华皮肤科杂志, 2023, 56(6): 540-544.
[11]	李容张家安陈崑. 玫瑰痤疮光电疗法研究进展[J]. 中华皮肤科杂志, 2023, 56(5): 468-470.
[12]	李嘉祺叶枫鞠强. 表皮葡萄球菌共生性稳态与皮肤疾病[J]. 中华皮肤科杂志, 2023, 56(5): 459-462.
[13]	王小燕张嘉文刘韵祎刘乙萱姜沛彧李敏陶梦许阳. 玫瑰痤疮的皮肤影像学和无创检测技术相关进展[J]. 中华皮肤科杂志, 2023, 56(4): 361-364.
[14]	孙静徐英男林彤薛劲松. 重度玫瑰痤疮眼型28例眼部损害临床治疗结局分析[J]. 中华皮肤科杂志, 2023, 56(2): 142-145.
[15]	王亚玲谢红付李吉汪犇. JAK-STAT信号通路与玫瑰痤疮[J]. 中华皮肤科杂志, 2023, 56(2): 169-172.

[开放获取] 从心身医学视角认识玫瑰痤疮

Insights into rosacea from the perspective of psychosomatic medicine

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 44

相关文章 15

Metrics

本文评价

推荐阅读 10